NFA
SUPN icon

Nationwide Fund Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History

Nationwide Fund Advisors’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-242,691
Closed -$9.71M – 1835
2017
Q3 		$9.71M Buy
242,691
+171,341
+240% +$7.42M 0.04% 663
2017
Q2 		$3.08M Buy
71,350
+8,698
+14% +$310K 0.01% 1249
2017
Q1 		$1.96M Sell
62,652
-13,682
-18% -$367K 0.01% 1406
2016
Q4 		$1.93M Sell
76,334
-22,494
-23% -$503K 0.01% 1424
2016
Q3 		$2.44M Sell
98,828
-2,620
-3% -$59.3K 0.01% 1291
2016
Q2 		$2.07M Buy
101,448
+7,469
+8% +$132K 0.01% 1344
2016
Q1 		$1.43M Sell
93,979
-4,289
-4% -$56K 0.01% 1513
2015
Q4 		$1.32M Sell
98,268
-539
-0.5% -$8.34K 0.01% 1578
2015
Q3 		$1.39M Sell
98,807
-3,500
-3% -$65.1K 0.01% 1557
2015
Q2 		$1.74M Buy
102,307
+2,324
+2% +$33.1K 0.01% 1525
2015
Q1 		$1.21M Buy
99,983
+1,033
+1% +$9.76K ﹤0.01% 1795
2014
Q4 		$821K Buy
98,950
+76,400
+339% +$642K ﹤0.01% 1913
2014
Q3 		$196K Buy
22,550
+234
+1% +$2.11K ﹤0.01% 2695
2014
Q2 		$244K Buy
22,316
+8,466
+61% +$75.4K ﹤0.01% 2652
2014
Q1 		$124K Buy
13,850
+1,672
+14% +$15.4K ﹤0.01% 2673
2013
Q4 		$92K Buy
12,178
+397
+3% +$2.78K ﹤0.01% 2979
2013
Q3 		$86K Buy
11,781
+5,048
+75% +$33.9K ﹤0.01% 2973
2013
Q2 		$43K Buy
+6,733
New +$39.7K ﹤0.01% 2983

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
RCAMU
Rothschild & Co Asset Management US Stamford, Connecticut $6.58B AUM 4.5% 1-Year Est. Return

Nationwide Fund Advisors's SUPN Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Supernus Pharmaceuticals (SUPN) in Q4 2017, closing a stake of 242,691 shares — an estimated $9.71M sold.

Nationwide Fund Advisors first reported a position in SUPN in Q2 2013 and held it in 18 quarters. The position peaked at $9.71M in Q3 2017. 297 funds tracked by Wall St. Rank hold SUPN as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Supernus Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 242,691 Supernus Pharmaceuticals shares in Q4 2017, an estimated $9.71M.
  • Nationwide Fund Advisors first reported a position in Supernus Pharmaceuticals in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's Supernus Pharmaceuticals position peaked at $9.71M in Q3 2017.
  • 297 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.